Table 5.
Comparison of the Patient, Disease and Treatment Characteristics Between (2012–2016) and (2017–2021), Univariate Analysis
| Characteristics | Group A | Group B | P value* |
|---|---|---|---|
| 2012–2016 | 2017–2021 | ||
| (n=109) | (n=151) | ||
| Patient-related | |||
| -Mean age, years (SD) | 68 (12.3) | 71 (10.9) | 0.07 |
| -Gender | 0.5 | ||
| Male | 83 (76%) | 120 (79%) | |
| Female | 26 (24%) | 31 (21%) | |
| Disease-related | |||
| -Histology | 0.3 | ||
| Urothelial | 91 (83%) | 136 (90%) | |
| Other | 13 (12%) | 12 (7.9%) | |
| Unknown | 5 (4.6%) | 3 (2.0%) | |
| -Stage† | 0.3 | ||
| Stage II | 16 (15%) | 33 (22%) | |
| Stage III | 30 (28%) | 39 (26%) | |
| Stage IV | 63 (58%) | 79 (52%) | |
| Treatment-related | |||
| -Intent | 0.3 | ||
| Curative | 45 (41%) | 72 (48%) | |
| Palliative | 64 (59%) | 79 (52%) |
Notes: †Stage according to UICC TNM Classification 8 ed. *Chi-square test for proportions and the independent t-test for continuous variables, statistical significance defined as P ≤ 0.05.
Abbreviation: SD, standard deviation.